2022-2028 年人胰岛素製剂和输送装置全球市场规模调查，按药物类型、装置类型和地区预测

2021 年全球人用胰岛素和输送设备市场价值约为 403 亿美元，预计在 2022-2028 年的预测期内以超过 3% 的健康增长率增长.

胰岛素是一种蛋白质激素，有助于控制身体无法製造足够胰岛素的人的高血糖水平。胰岛素通过促进脂肪组织和肌肉中的葡萄糖摄取来降低血糖水平。它可以注射到臀部、腹部、手臂后部或腿部。此外，胰岛素不仅用于帮助控製糖尿病，还用于治疗其直接后果，如糖尿病酮症酸中毒和高渗性高血□□糖。市场增长的主要因素包括糖尿病患者数量的增加和对 HI 类似物的市场需求不断增长。根据联邦基金的一项研究，与那些有医疗补助或私人保险的人相比，没有保险的糖尿病患者使用更老、更便宜（且效果更差）的胰岛素产品。 60% 到 80% 的未投保人为胰岛素支付全价，相比之下，9% 的私人投保人和 3% 的 Medicaid 接受者支付全价。此外，关键 HI 药物专利的预期到期将增加全球市场机会。然而，对产品批准的严格监管要求正在阻碍 2022-2028 年预测期内的市场增长。

在人胰岛素製剂和输送设备的全球市场研究中考虑的主要地区是亚太地区、北美、欧洲、拉丁美洲和世界其他地区。由于糖尿病病例的数量不断增加，北美在整体市场份额中处于领先地位。然而，由于人们生活方式的改变和不健康的饮食习惯，预计亚太地区将成为增长最快的地区。

本报告中包括的主要市场参与者是：

• Novo Nordisk A/S
• Insulet
• Eli Lilly
• Exir
• Biocon
• Becton Dickinson
• Medtronic
• Ypsomed
• Julphar
• Sanofi Aventis

本研究的目的是明确近年来各个细分市场和国家的市场规模，并预测未来八年的市场规模。该报告旨在包括所涵盖的每个地区和国家的行业的定性和定量方面。此外，它还提供了有关关键方面的详细信息，例如定义市场未来增长的驱动因素和挑战。此外，该报告还应纳入微观市场中可供利益相关者投资的可用机会，以及对竞争格局和主要参与者的应用产品的深入分析。市场的详细细分和子细分如下所述。

按药物类型。

基础或长效胰岛素

推注或速效胰岛素

常规人胰岛素

结合胰岛素

生物仿製药胰岛素

按设备类型

胰岛素笔

胰岛素泵

胰岛素注射器

喷射喷射器

按地区

北美

美国

加拿大

欧洲

英国

德国

法国

西班牙

意大利

其他欧洲

亚太地区

中国

印度

日本

澳大利亚

韩国

其他亚太地区

拉丁美洲

巴西

墨西哥

世界其他地方

此外，本研究考虑的年份是：

实际年份 - 2018 年、2019 年、2020 年

2021 年基准年

预测期 - 2022 年 至 2028 年

本报告的目标受众是全球人胰岛素製剂和输送设备市场。

主要咨询公司和顾问

大公司、中型公司、中小企业

风险投资

增值经销商 (VAR)

第三方知识提供者

投资银行家

投资者

内容

第 1 章执行摘要

• 市场快照
• 2020-2028 年全球市场和细分市场估计和预测
  • 2020-2028 年人用胰岛素和输送设备市场：按地区分列
  • 2020-2028 年按药物类型分列的人胰岛素製剂和给药装置市场
  • 2020-2028 年按设备类型分列的人胰岛素製剂和输送设备市场
• 主要趋势
• 调查方法
• 调查先决条件

第 2 章。人胰岛素製剂和输送设备全球市场的定义和范围

• 调查目的
• 市场定义和范围
  • 调查范围
  • 工业发展
• 调查年份
• 货币兑换率

第 3 章人胰岛素製剂和输送装置的全球市场动态

• 人胰岛素製剂和输送装置的市场影响分析（2020-2028 年）
  • 市场驱动力
    • 糖尿病患者人数增加
    • 市场对 HI 类似物的需求增加
  • 市场挑战
    • 对产品批准的严格监管要求
  • 市场机会
    • 主要 HI 药物的专利到期
    • 新兴市场

第 4 章全球人用胰岛素产品和输送设备市场行业分析

• 波特的 5 力模型
  • 供应商的议价能力
  • 买家的议价能力
  • 新进入者的威胁
  • 替代品的威胁
  • 竞争公司之间的敌对关係
  • 波特 5 力模型的未来方法（2018-2028）
• PEST 分析
  • 政治
  • 经济
  • 社交
  • 技术
• 招商引资模式
• 分析师的结论和建议
• 热门投资机会
• 关键成功策略

第 5 章风险评估：COVID-19 的影响

• 评估 COVID-19 对行业的整体影响
• COVID-19 之前和 COVID-19 之后的市场情景

第 6 章。人类胰岛素和输送设备的全球市场：按药物类型

• 市场快照
• 人胰岛素製剂和递送装置的全球市场：按药物类型、性能潜力分析
• 2018-2028 年世界人用胰岛素和递送装置市场、按药物类型估计和预测
• 人胰岛素製剂和输送设备市场，细分分析
  • 基础胰岛素或长效胰岛素
  • 推注或速效胰岛素製剂
  • 常规人胰岛素
  • 复合胰岛素
  • 生物仿製药胰岛素

第 7 章。按设备类型分列的人用胰岛素和输送设备全球市场

• 市场快照
• 人用胰岛素和输送设备的全球市场：按设备类型进行的性能潜力分析
• 2018-2028 年全球人用胰岛素和输送设备市场、按设备类型估计和预测
• 人胰岛素製剂和输送设备市场，细分分析
  • 胰岛素笔
  • 胰岛素泵
  • 胰岛素注射器
  • 喷射喷射器

第 8 章全球人类胰岛素和输送设备市场：区域分析

• 人胰岛素製剂和输送设备市场，按地区分列的市场快照
• 北美
  • 美国
    • 按药物类型划分的估计和预测，2018-2028 年
    • 按设备类型划分的估计和预测，2018-2028 年
  • 加拿大
• 欧洲人胰岛素製剂和输送设备的市场概况
  • 英国
  • 德国
  • 法国
  • 西班牙
  • 意大利
  • 其他欧洲地区
• 亚太地区人用胰岛素和输送设备市场概览
  • 中国
  • 印度
  • 日本
  • 澳大利亚
  • 韩国
  • 其他亚太地区
• 拉丁美洲人胰岛素和递送设备市场快照
  • 巴西
  • 墨西哥
• 世界其他地区

第 9 章衝突信息

• 顶级市场策略
• 公司简介
  • Sanofi Aventis
    • 主要信息
    • 概览
    • 财务（如果有数据）
    • 产品概览
    • 近期发展状况
  • Novo Nordisk A/S
  • Insulet
  • Eli Lilly
  • Exir
  • Biocon
  • Becton Dickinson
  • Medtronic
  • Ypsomed
  • Julphar

第十章研究过程

• 研究过程
  • 数据挖掘
  • 分析
  • 市场估算
  • 验证
  • 出版
• 调查属性
• 调查先决条件

Global Human Insulin Drugs and Delivery Devices Market is valued at approximately USD 40.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 3% over the forecast period 2022-2028. Protein hormone insulin helps people whose systems are unable to manufacture enough insulin control high blood sugar levels. By enhancing glucose uptake in fatty tissues and muscles, insulin reduces the blood glucose level. This can be infused in buttocks, belly, backs of the arms, or legs. Additionally, insulin not only aids in the management of diabetes but also in the treatment of its immediate consequences, including diabetic ketoacidosis and hyperosmolar hyperglycemia. The market growth is driven by key factors such as growth in the number of diabetic patients and rising market demand for HI Analogs. According to a Commonwealth Fund study, Americans with diabetes who lack insurance are more likely to use older, less expensive (and less effective) insulin medications than those who have Medicaid or private insurance. 60% to 80% of people without insurance pay the entire list price for insulin, compared to 9% of privately insured patients and 3% of Medicaid recipients. Moreover, expected patent expiry of key HI Drugs propels the market opportunities across the globe. However, stringent regulatory requirements for product approval impede the growth of the market over the forecast period of 2022-2028.

The key regions considered for the global Human Insulin Drugs and Delivery Devices Market study include Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is leading the overall market share owing to high cases and increasing amount of diabetic patients. However, Asia Pacific is expected to be the fastest growing region due to changing lifestyles of people and unhealthy dietary habits.

Major market players included in this report are:

Novo Nordisk A/S

Insulet

Eli Lilly

Exir

Biocon

Becton Dickinson

Medtronic

Ypsomed

Julphar

Sanofi Aventis

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and Application offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Drug Type:

Basal or Long-acting Insulins

Bolus or Fast-acting Insulins

Traditional Human Insulins

Combination Insulins

Biosimilar Insulins

By Device Type:

Insulin Pens

Insulin Pumps

Insulin Syringes

Jet Injectors

By Region:

North America

U.S.

Canada

Europe

UK

Germany

France

Spain

Italy

ROE

Asia Pacific

China

India

Japan

Australia

South Korea

RoAPAC

Latin America

Brazil

Mexico

Rest of the World

Furthermore, years considered for the study are as follows:

Historical year - 2018, 2019, 2020

Base year - 2021

Forecast period - 2022 to 2028

Target Audience of the Global Human Insulin Drugs and Delivery Devices Market in Market Study:

Key Consulting Companies & Advisors

Large, medium-sized, and small enterprises

Venture capitalists

Value-Added Resellers (VARs)

Third-party knowledge providers

Investment bankers

Investors

Table of Contents

Chapter 1. Executive Summary

• 1.1. Market Snapshot
• 1.2. Global & Segmental Market Estimates & Forecasts, 2020-2028 (USD Billion)
  • 1.2.1. Human Insulin Drugs and Delivery Devices Market, by region, 2020-2028 (USD Billion)
  • 1.2.2. Human Insulin Drugs and Delivery Devices Market, by Drug Type, 2020-2028 (USD Billion)
  • 1.2.3. Human Insulin Drugs and Delivery Devices Market, by Device Type, 2020-2028 (USD Billion)
• 1.3. Key Trends
• 1.4. Estimation Methodology
• 1.5. Research Assumption

Chapter 2. Global Human Insulin Drugs and Delivery Devices Market Definition and Scope

• 2.1. Objective of the Study
• 2.2. Market Definition & Scope
  • 2.2.1. Scope of the Study
  • 2.2.2. Industry Evolution
• 2.3. Years Considered for the Study
• 2.4. Currency Conversion Rates

Chapter 3. Global Human Insulin Drugs and Delivery Devices Market Dynamics

• 3.1. Human Insulin Drugs and Delivery Devices Market Impact Analysis (2020-2028)
  • 3.1.1. Market Drivers
    • 3.1.1.1. Growth in the Number of Diabetic Patients
    • 3.1.1.2. Rising Market Demand for HI Analogs
  • 3.1.2. Market Challenges
    • 3.1.2.1. Stringent Regulatory Requirements for Product Approval
  • 3.1.3. Market Opportunities
    • 3.1.3.1. Expected Patent Expiry of Key HI Drugs
    • 3.1.3.2. Emerging Markets

Chapter 4. Global Human Insulin Drugs and Delivery Devices Market Industry Analysis

• 4.1. Porter's 5 Force Model
  • 4.1.1. Bargaining Power of Suppliers
  • 4.1.2. Bargaining Power of Buyers
  • 4.1.3. Threat of New Entrants
  • 4.1.4. Threat of Substitutes
  • 4.1.5. Competitive Rivalry
  • 4.1.6. Futuristic Approach to Porter's 5 Force Model (2018-2028)
• 4.2. PEST Analysis
  • 4.2.1. Political
  • 4.2.2. Economical
  • 4.2.3. Social
  • 4.2.4. Technological
• 4.3. Investment Adoption Model
• 4.4. Analyst Recommendation & Conclusion
• 4.5. Top investment opportunity
• 4.6. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

• 5.1.1. Assessment of the overall impact of COVID-19 on the industry
• 5.1.2. Pre COVID-19 and post COVID-19 market scenario

Chapter 6. Global Human Insulin Drugs and Delivery Devices Market, by Drug Type

• 6.1. Market Snapshot
• 6.2. Global Human Insulin Drugs and Delivery Devices Market by Drug Type, Performance - Potential Analysis
• 6.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Drug Type, 2018-2028 (USD Billion)
• 6.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
  • 6.4.1. Basal or Long-acting Insulins
  • 6.4.2. Bolus or Fast-acting Insulins
  • 6.4.3. Traditional Human Insulins
  • 6.4.4. Combination Insulins
  • 6.4.5. Biosimilar Insulins

Chapter 7. Global Human Insulin Drugs and Delivery Devices Market, by Device Type

• 7.1. Market Snapshot
• 7.2. Global Human Insulin Drugs and Delivery Devices Market by Device Type, Performance - Potential Analysis
• 7.3. Global Human Insulin Drugs and Delivery Devices Market Estimates & Forecasts by Device Type, 2018-2028 (USD Billion)
• 7.4. Human Insulin Drugs and Delivery Devices Market, Sub Segment Analysis
  • 7.4.1. Insulin Pens
  • 7.4.2. Insulin Pumps
  • 7.4.3. Insulin Syringes
  • 7.4.4. Jet Injectors

Chapter 8. Global Human Insulin Drugs and Delivery Devices Market, Regional Analysis

• 8.1. Human Insulin Drugs and Delivery Devices Market, Regional Market Snapshot
• 8.2. North America Human Insulin Drugs and Delivery Devices Market
  • 8.2.1. U.S. Human Insulin Drugs and Delivery Devices Market
    • 8.2.1.1. Drug Type breakdown estimates & forecasts, 2018-2028
    • 8.2.1.2. Device Type breakdown estimates & forecasts, 2018-2028
  • 8.2.2. Canada Human Insulin Drugs and Delivery Devices Market
• 8.3. Europe Human Insulin Drugs and Delivery Devices Market Snapshot
  • 8.3.1. U.K. Human Insulin Drugs and Delivery Devices Market
  • 8.3.2. Germany Human Insulin Drugs and Delivery Devices Market
  • 8.3.3. France Human Insulin Drugs and Delivery Devices Market
  • 8.3.4. Spain Human Insulin Drugs and Delivery Devices Market
  • 8.3.5. Italy Human Insulin Drugs and Delivery Devices Market
  • 8.3.6. Rest of Europe Human Insulin Drugs and Delivery Devices Market
• 8.4. Asia-Pacific Human Insulin Drugs and Delivery Devices Market Snapshot
  • 8.4.1. China Human Insulin Drugs and Delivery Devices Market
  • 8.4.2. India Human Insulin Drugs and Delivery Devices Market
  • 8.4.3. Japan Human Insulin Drugs and Delivery Devices Market
  • 8.4.4. Australia Human Insulin Drugs and Delivery Devices Market
  • 8.4.5. South Korea Human Insulin Drugs and Delivery Devices Market
  • 8.4.6. Rest of Asia Pacific Human Insulin Drugs and Delivery Devices Market
• 8.5. Latin America Human Insulin Drugs and Delivery Devices Market Snapshot
  • 8.5.1. Brazil Human Insulin Drugs and Delivery Devices Market
  • 8.5.2. Mexico Human Insulin Drugs and Delivery Devices Market
• 8.6. Rest of The World Human Insulin Drugs and Delivery Devices Market

Chapter 9. Competitive Intelligence

• 9.1. Top Market Strategies
• 9.2. Company Profiles
  • 9.2.1. Sanofi Aventis
    • 9.2.1.1. Key Information
    • 9.2.1.2. Overview
    • 9.2.1.3. Financial (Subject to Data Availability)
    • 9.2.1.4. Product Summary
    • 9.2.1.5. Recent Developments
  • 9.2.2. Novo Nordisk A/S
  • 9.2.3. Insulet
  • 9.2.4. Eli Lilly
  • 9.2.5. Exir
  • 9.2.6. Biocon
  • 9.2.7. Becton Dickinson
  • 9.2.8. Medtronic
  • 9.2.9. Ypsomed
  • 9.2.10. Julphar

Chapter 10. Research Process

• 10.1. Research Process
  • 10.1.1. Data Mining
  • 10.1.2. Analysis
  • 10.1.3. Market Estimation
  • 10.1.4. Validation
  • 10.1.5. Publishing
• 10.2. Research Attributes
• 10.3. Research Assumption

LIST OF TABLES

• TABLE 1. Global Human Insulin Drugs and Delivery Devices Market, report scope
• TABLE 2. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Region 2018-2028 (USD Billion)
• TABLE 3. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Drug Type 2018-2028 (USD Billion)
• TABLE 4. Global Human Insulin Drugs and Delivery Devices Market estimates & forecasts by Device Type 2018-2028 (USD Billion)
• TABLE 5. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 6. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 7. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 8. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 9. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 10. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 11. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 12. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 13. Global Human Insulin Drugs and Delivery Devices Market by segment, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 14. Global Human Insulin Drugs and Delivery Devices Market by region, estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 15. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 16. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 17. U.S. Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 18. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 19. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 20. Canada Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 21. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 22. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 23. UK Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 24. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 25. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 26. Germany Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 27. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 28. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 29. RoE Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 30. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 31. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 32. China Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 33. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 34. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 35. India Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 36. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 37. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 38. Japan Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 39. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 40. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 41. RoAPAC Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 42. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 43. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 44. Brazil Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 45. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 46. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 47. Mexico Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 48. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 49. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 50. RoLA Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 51. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts, 2018-2028 (USD Billion)
• TABLE 52. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 53. Row Human Insulin Drugs and Delivery Devices Market estimates & forecasts by segment 2018-2028 (USD Billion)
• TABLE 54. List of secondary sources, used in the study of global Human Insulin Drugs and Delivery Devices Market
• TABLE 55. List of primary sources, used in the study of global Human Insulin Drugs and Delivery Devices Market
• TABLE 56. Years considered for the study
• TABLE 57. Exchange rates considered

LIST OF FIGURES

List of figures

• FIG 1. Global Human Insulin Drugs and Delivery Devices Market, research methodology
• FIG 2. Global Human Insulin Drugs and Delivery Devices Market, market estimation techniques
• FIG 3. Global market size estimates & forecast methods
• FIG 4. Global Human Insulin Drugs and Delivery Devices Market, key trends 2021
• FIG 5. Global Human Insulin Drugs and Delivery Devices Market, growth prospects 2022-2028
• FIG 6. Global Human Insulin Drugs and Delivery Devices Market, porters 5 force model
• FIG 7. Global Human Insulin Drugs and Delivery Devices Market, pest analysis
• FIG 8. Global Human Insulin Drugs and Delivery Devices Market, value chain analysis
• FIG 9. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
• FIG 10. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
• FIG 11. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
• FIG 12. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
• FIG 13. Global Human Insulin Drugs and Delivery Devices Market by segment, 2018 & 2028 (USD Billion)
• FIG 14. Global Human Insulin Drugs and Delivery Devices Market, regional snapshot 2018 & 2028
• FIG 15. North America Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
• FIG 16. Europe Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
• FIG 17. Asia Pacific Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
• FIG 18. Latin America Human Insulin Drugs and Delivery Devices Market 2018 & 2028 (USD Billion)
• FIG 19. Global Human Insulin Drugs and Delivery Devices Market, company market share analysis (2021)